Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector - PubMed (original) (raw)
Constitutive and enhanced expression from the CMV major IE promoter in a defective adenovirus vector
G W Wilkinson et al. Nucleic Acids Res. 1992.
Free PMC article
Abstract
A defective adenovirus (Ad) type 5 E1- vector has been combined with the powerful constitutive cytomegalovirus (CMV) major immediate early (IE) promoter to produce a novel eukaryotic expression system. The Ad vector can replicate to high titres in 293 cells and then be used to infect a wide variety of non-permissive cell types. The Escherichia coli lacZ and CMV IE1 genes have been cloned to generate the Ad recombinants RAd35 and RAd31 respectively. In human fibroblasts infected with RAd35 beta-galactosidase (beta-gal) expression could be detected in virtually 100% of target cells, there was no detectable transcription from the Ad genome and extremely high levels of expression could be achieved with beta-gal representing the predominant cytoplasmic cellular protein. Additionally, a number of agents, including the CMV IE1 gene product (in RAd31) and forskolin, significantly enhanced expression from RAd35-infected human fibroblasts. Lower levels of constitutive beta-gal expression were obtained in RAd35-infected HeLa cells but again expression could be enhanced (up to 60 fold) by chemical inducing agents. Expression from the IE promoter in the Ad vector could be repressed by coinfection with CMV.
Similar articles
- Comparison of the human versus murine cytomegalovirus immediate early gene promoters for transgene expression by adenoviral vectors.
Addison CL, Hitt M, Kunsken D, Graham FL. Addison CL, et al. J Gen Virol. 1997 Jul;78 ( Pt 7):1653-61. doi: 10.1099/0022-1317-78-7-1653. J Gen Virol. 1997. PMID: 9225042 - Cell type-specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is inserted into herpesvirus or adenovirus vectors.
Shering AF, Bain D, Stewart K, Epstein AL, Castro MG, Wilkinson GW, Lowenstein PR. Shering AF, et al. J Gen Virol. 1997 Feb;78 ( Pt 2):445-59. doi: 10.1099/0022-1317-78-2-445. J Gen Virol. 1997. PMID: 9018068 - Investigation of promoter function in human and animal cells infected with human recombinant adenovirus expressing rotavirus antigen VP7sc.
Xu ZZ, Krougliak V, Prevec L, Graham FL, Both GW. Xu ZZ, et al. J Gen Virol. 1995 Aug;76 ( Pt 8):1971-80. doi: 10.1099/0022-1317-76-8-1971. J Gen Virol. 1995. PMID: 7636477 - Gene transfer into enteric neurons of the rat small intestine in organ culture using a replication defective recombinant herpes simplex virus type 1 (HSV1) vector, but not recombinant adenovirus vectors.
Brown OA, Santer RM, Shering AF, Larregina AT, Morelli AE, Southgate TD, Castro MG, Lowenstein PR. Brown OA, et al. Gene Ther. 1997 Apr;4(4):331-8. doi: 10.1038/sj.gt.3300383. Gene Ther. 1997. PMID: 9176519 - Promoters and regulatory elements that improve adeno-associated virus transgene expression in the brain.
Fitzsimons HL, Bland RJ, During MJ. Fitzsimons HL, et al. Methods. 2002 Oct;28(2):227-36. doi: 10.1016/s1046-2023(02)00227-x. Methods. 2002. PMID: 12413421 Review.
Cited by
- Inhibition of TGF-β signaling, invasion, and growth of cutaneous squamous cell carcinoma by PLX8394.
Siljamäki E, Riihilä P, Suwal U, Nissinen L, Rappu P, Kallajoki M, Kähäri VM, Heino J. Siljamäki E, et al. Oncogene. 2023 Dec;42(49):3633-3647. doi: 10.1038/s41388-023-02863-8. Epub 2023 Oct 20. Oncogene. 2023. PMID: 37864034 Free PMC article. - Super Enhancer-Regulated LINC00094 (SERLOC) Upregulates the Expression of MMP-1 and MMP-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma.
Piipponen M, Riihilä P, Knuutila JS, Kallajoki M, Kähäri VM, Nissinen L. Piipponen M, et al. Cancers (Basel). 2022 Aug 17;14(16):3980. doi: 10.3390/cancers14163980. Cancers (Basel). 2022. PMID: 36010973 Free PMC article. - Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.
Gabitzsch E, Safrit JT, Verma M, Rice A, Sieling P, Zakin L, Shin A, Morimoto B, Adisetiyo H, Wong R, Bezawada A, Dinkins K, Balint J, Peykov V, Garban H, Liu P, Bacon A, Bone P, Drew J, Sanford DC, Spilman P, Sender L, Rabizadeh S, Niazi K, Soon-Shiong P. Gabitzsch E, et al. Front Immunol. 2021 Sep 16;12:729837. doi: 10.3389/fimmu.2021.729837. eCollection 2021. Front Immunol. 2021. PMID: 34603305 Free PMC article. - Design and Application of A Bioluminescent Biosensor for Detection Of Toxicity Using Huh7-CMV-Luc Cell Line.
Rahimirad N, Kavoosi S, Shirzad H, Sadeghizadeh M. Rahimirad N, et al. Iran J Pharm Res. 2019 Spring;18(2):686-695. doi: 10.22037/ijpr.2019.1100687. Iran J Pharm Res. 2019. PMID: 31531052 Free PMC article. - Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy.
Dai B, Yan S, Lara-Guerra H, Kawashima H, Sakai R, Jayachandran G, Majidi M, Mehran R, Wang J, Bekele BN, Baladandayuthapani V, Yoo SY, Wang Y, Ying J, Meng F, Ji L, Roth JA. Dai B, et al. PLoS One. 2015 Jun 8;10(6):e0123967. doi: 10.1371/journal.pone.0123967. eCollection 2015. PLoS One. 2015. PMID: 26053020 Free PMC article.
References
- Cell. 1992 Jan 10;68(1):143-55 - PubMed
- J Gen Virol. 1977 Jul;36(1):59-74 - PubMed
- Nucleic Acids Res. 1991 Jan 25;19(2):319-25 - PubMed
- J Virol. 1991 Feb;65(2):887-96 - PubMed
- J Virol. 1991 Feb;65(2):897-903 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources